pCW57-RFP-P2A-MCS Citations (5)
Originally described in: Pan-Cancer Analyses Reveal Genomic Features of FOXM1 Overexpression in Cancer.Barger CJ, Branick C, Chee L, Karpf AR Cancers (Basel). 2019 Feb 21;11(2). pii: cancers11020251. doi: 10.3390/cancers11020251. PubMed Journal
Articles Citing pCW57-RFP-P2A-MCS
Articles |
---|
Establishment of a Reverse Genetic System from a Bovine Derived Influenza D Virus Isolate. Holwerda M, Laloli L, Wider M, Schonecker L, Becker J, Meylan M, Dijkman R. Viruses. 2021 Mar 18;13(3). pii: v13030502. doi: 10.3390/v13030502. PubMed |
G3BP1 inhibits Cul3(SPOP) to amplify AR signaling and promote prostate cancer. Mukhopadhyay C, Yang C, Xu L, Liu D, Wang Y, Huang D, Deonarine LD, Cyrta J, Davicioni E, Sboner A, Robinson BD, Chinnaiyan AM, Rubin MA, Barbieri CE, Zhou P. Nat Commun. 2021 Nov 18;12(1):6662. doi: 10.1038/s41467-021-27024-x. PubMed |
Rapid binding to protofilament edge sites facilitates tip tracking of EB1 at growing microtubule plus-ends. Gonzalez SJ, Heckel JM, Goldblum RR, Reid TA, McClellan M, Gardner MK. Elife. 2024 Feb 22;13:e91719. doi: 10.7554/eLife.91719. PubMed |
Nek2A prevents centrosome clustering and induces cell death in cancer cells via KIF2C interaction. Kalkan BM, Ozcan SC, Cicek E, Gonen M, Acilan C. Cell Death Dis. 2024 Mar 16;15(3):222. doi: 10.1038/s41419-024-06601-0. PubMed |
Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis. Zhang Y, Fong KW, Mao F, Wang R, Allison DB, Napier D, He D, Liu J, Zhang Y, Chen J, Kong Y, Li C, Li G, Liu J, Li Z, Zhu H, Wang C, Liu X. Cell Rep. 2024 Jul 23;43(7):114431. doi: 10.1016/j.celrep.2024.114431. Epub 2024 Jul 4. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.